-
Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
03 Mar 2021 13:00 GMT
… for Glatopa™, the sNDA for Integrilin™, as well as numerous INDs … . Following its partnership with Vertex Pharmaceuticals, Arbor recently announced an agreement … editing platform. About Arbor Biotechnologies
Arbor Biotechnologies is an early-stage company …
-
Snake venom is a boon in search for life-saving drugs
09 Nov 2020 10:27 GMT
… his team administered blood thinners, including Integrilin, to help … founder of ToxinTech, a biotech startup that houses a … on herbal remedies in traditional Chinese medicine, she found … several malaria drugs.
References to venom as medical treatments also go …
-
Medicure, Inc. (MCUJF) CEO Albert Friesen on Q3 2020 Results - Earnings Call Transcript
14 Nov 2020 06:10 GMT
… generic versions of Integrilin when compared to Q3 … when U.S. trial resumes.
The sales of … for other statins and its accessibility in terms … and distribution.
Medicure continues to develop additional cardiovascular abbreviated new drug applications, or …
-
This life-saving medicine is made from snake venom
11 Nov 2020 06:32 GMT
… the cardiovascular system. Doctors have seen blood clotting as one of … of the University of Chicago Medicine, in CNN, revealed that … who suffered from a massive heart attack. A procedure was … Among the blood thinners used was Integrilin, a drug approved by the …
-
Medicure, Inc. (MCUJF) CEO Albert Friesen on Q2 2020 Results - Earnings Call Transcript
12 Aug 2020 19:31 GMT
… of 677,000 of FDA fees previously paid, which … unrestricted educational grant from Medicure.
The study showed significant … received a waiver on FDA fees, which was actually refunded … competition from a different drug called Integrilin or after active fiber …
-
Medicure's (MCUJF) CEO Albert Friesen on Q4 2019 Results - Earnings Call Transcript
16 Apr 2020 15:12 GMT
… from generic versions of Integrilin as some volume decrease has … the ZYPITAMAG new drug application or NDA in Q3 … over other statins directly to consumers.
At the end of 2019 Medicure implemented … s called STEMI emergency heart attacks. And although there' …
-
Medicure: How To Destroy A Company
16 May 2020 13:05 GMT
… biotech companies. It had one early-stage candidate in trials … drug used in acute hospital settings for treatment of unstable angina. With angina, coronary arteries … cap pharmaceutical company could make. In fact, Medicure … Integrilin market which has …
-
What to know about blood thinners for heart disease
29 Nov 2019 05:28 GMT
… deposits in the arteries.
Blood clots can partially … drugs include:
tirofiban (Aggrastat)
eptifibatide (Integrilin)
Anticoagulants
In some situations, doctors … blood:
Blood thinners include antiplatelet and anticoagulant medications. People who have a blood …
-
Medicure completes enrollment in SAVI─PCI study
19 Dec 2019 10:25 GMT
Medicure, a cardiovascular pharmaceutical company, announced … Integrilin (eptifibatide) in Percutaneous Coronary Intervention (SAVI-PCI) clinical trial … the SAVI-PCI trial will be communicated … Friesen, PhD, CEO of Medicure.
Aggrastat (tirofiban hydrochloride) …
-
Medicure Inc. (MCUJF) CEO Albert Friesen on Q3 2019 Results - Earnings Call Transcript
27 Nov 2019 15:58 GMT
…
Pricing pressure from generic Integrilin products has impacted net … and specialized formularies.
Medicure announced that it has … 2019 Heart Failure Society of America conference. This trial … cardiovascular abbreviated New Drug Applications or ANDAs …